THC for Cannabis

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
CannabisTHC - Drug
Eligibility
18 - 55
All Sexes
What conditions do you have?
Select

Study Summary

This trial will study how men and women differ in their reaction to marijuana.

Eligible Conditions
  • Cannabis

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: 25 minutes after THC infusion begins

25 minutes after THC infusion begins
Verbal Learning: measured by Rey Auditory Verbal Learning Test (AVLT)
changes in "high" assessed over the following timepoints: baseline, +10, +80, and +200 minutes after THC infusion begins
Rewarding Effects measured by Visual Analog Scale (VAS)

Trial Safety

Trial Design

2 Treatment Groups

THC
1 of 2
Placebo
1 of 2

Active Control

Non-Treatment Group

100 Total Participants · 2 Treatment Groups

Primary Treatment: THC · Has Placebo Group · Phase 1

Placebo
Drug
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: Drug
THC
Drug
ActiveComparator Group · 1 Intervention: THC · Intervention Types: Drug

Trial Logistics

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 25 minutes after thc infusion begins

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,679 Previous Clinical Trials
21,087,939 Total Patients Enrolled
13 Trials studying Cannabis
663 Patients Enrolled for Cannabis

Eligibility Criteria

Age 18 - 55 · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: